Meridian Bioscience Analysis
Meridian Bioscience holds a debt-to-equity ratio of 0.087. With a high degree of financial leverage come high-interest payments, which usually reduce Meridian Bioscience's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Meridian Bioscience's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Meridian Bioscience's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Meridian Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Meridian Bioscience's stakeholders.
For most companies, including Meridian Bioscience, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Meridian Bioscience, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Meridian Bioscience's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Meridian Stock price history is provided at the adjusted basis, taking into account all of the recent filings. Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VIVO |
Based on monthly moving average Meridian Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Meridian Bioscience by adding Meridian Bioscience to a well-diversified portfolio.
Given that Meridian Bioscience's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Meridian Bioscience is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Meridian Bioscience to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Meridian Bioscience is said to be less leveraged. If creditors hold a majority of Meridian Bioscience's assets, the Company is said to be highly leveraged.
Meridian Bioscience is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Meridian Bioscience delisted stock analysis is to determine its intrinsic value, which is an estimate of what Meridian Bioscience is worth, separate from its market price. There are two main types of Meridian Bioscience's stock analysis: fundamental analysis and technical analysis.
The Meridian Bioscience stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Meridian Bioscience is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Meridian Stock trading window is adjusted to America/New York timezone.
Meridian |
Meridian Stock Analysis Notes
About 91.0% of the company outstanding shares are owned by institutional investors. The book value of Meridian Bioscience was at this time reported as 8.41. The company has Price/Earnings To Growth (PEG) ratio of 1.33. Meridian Bioscience last dividend was issued on the 1st of February 2019. The entity had 3:2 split on the 14th of May 2007. Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 702 people. For more information please call John Kenny at 513 271 3700 or visit https://www.meridianbioscience.com.Meridian Bioscience Investment Alerts
| Meridian Bioscience is not yet fully synchronised with the market data | |
| Meridian Bioscience has some characteristics of a very speculative penny stock | |
| Meridian Bioscience has a very high chance of going through financial distress in the upcoming years | |
| Over 91.0% of the company outstanding shares are owned by institutional investors |
Meridian Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.49 B.Meridian Profitablity
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.Meridian Bioscience Outstanding Bonds
Meridian Bioscience issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Meridian Bioscience uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Meridian bonds can be classified according to their maturity, which is the date when Meridian Bioscience has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Meridian Bioscience Debt to Cash Allocation
As Meridian Bioscience follows its natural business cycle, the capital allocation decisions will not magically go away. Meridian Bioscience's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Meridian Bioscience currently holds 25 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Meridian Bioscience has a current ratio of 3.45, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Meridian Bioscience's use of debt, we should always consider it together with its cash and equity.Meridian Bioscience Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Meridian Bioscience's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Meridian Bioscience, which in turn will lower the firm's financial flexibility.Meridian Bioscience Corporate Bonds Issued
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Meridian Bioscience to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Meridian Stock
If you are still planning to invest in Meridian Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Meridian Bioscience's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |